Cardio Diagnostics Holdings Inc. Common stock Share Price
CDIOCardio Diagnostics Holdings Inc. Common stock Stock Performance
Open $2.90 | Prev. Close $2.90 | Circuit Range N/A |
Day Range $2.90 - $2.90 | Year Range $2.47 - $52.80 | Volume 111 |
Average Traded $2.90 |
Cardio Diagnostics Holdings Inc. Common stock Share Price Chart
About Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Cardio Diagnostics Holdings Inc. Common stock Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
04-Dec-25 | $2.90 | $2.90 | +0.00% |
04-Dec-25 | $2.90 | $2.90 | -3.49% |
25-Nov-25 | $3.01 | $3.01 | +8.66% |
24-Nov-25 | $2.77 | $2.77 | +12.15% |
19-Nov-25 | $2.47 | $2.47 | -8.18% |
18-Nov-25 | $2.79 | $2.69 | -11.22% |
17-Nov-25 | $3.17 | $3.03 | -21.71% |